Peptides sound ideal for scalp care: they are small chains of amino acids, and laboratory studies suggest that certain peptides can interact with skin and follicle-associated cells. But there is a basic problem every topical peptide has to solve first.
It has to get where it is supposed to go.
Human skin is specifically designed to keep foreign molecules out. That makes “delivery” one of the most important — and most misunderstood — subjects in peptide cosmetics. A useful place to start is the famous “500 Dalton rule.”
The 500 Dalton Rule
In 2000, dermatology researchers Jan Bos and Marcus Meinardi proposed that molecules generally need a molecular weight below approximately 500 Daltons (Da) to penetrate intact skin efficiently enough to matter for topical delivery (Bos & Meinardi, Experimental Dermatology, 2000). Their argument was based on the observation that common contact allergens and successful topical drugs overwhelmingly fall below this size.
But “500 Daltons” should not be treated as a magical doorway. A molecule weighing 499 Da is not automatically absorbed while one at 501 Da is completely blocked — molecular weight is one part of a much more complicated permeability problem.
The outermost skin layer — the stratum corneum — is often described as a brick wall: the “bricks” are dead, keratin-filled corneocytes, and the mortar is a highly organized lipid matrix. To move through that barrier, a molecule needs the right combination of size, charge, polarity, lipid solubility and hydrogen-bonding characteristics. Peptides can struggle because peptide bonds and amino-acid side chains often make them relatively polar and water-loving. That means even a peptide comfortably below 500 Da may penetrate poorly.
Small Peptides Have an Advantage — Not a Guarantee
This distinction becomes obvious when researchers actually measure peptide penetration.
Acetyl hexapeptide-8, commonly known as Argireline, is substantially larger than 500 Da (about 889 Da). In an in-vitro experiment using human skin, most of the applied peptide remained on or near the surface: approximately 0.22% of the applied dose was detected in the stratum corneum and about 0.01% in the epidermis, with none detected in the receptor fluid beneath the skin (Kraeling et al., Journal of Cutaneous and Ocular Toxicology, 2015).
That is a useful reminder that putting a biologically interesting peptide into a cream does not automatically mean meaningful amounts reach deeper tissue.
Researchers therefore modify some cosmetic peptides to improve their relationship with the skin barrier. One strategy is attaching a fatty-acid chain — “palmitoylation” — which makes the peptide more lipid-friendly. But increased lipophilicity does not automatically solve the problem either: experimental work with cosmetic peptides has shown that molecular size, polar surface area and hydrogen bonding can all restrict diffusion through intact skin.
What About Copper Tripeptides?
Copper tripeptides are particularly interesting here because they are comparatively small.
GHK is the three-amino-acid sequence glycine-histidine-lysine. Published human-skin diffusion experiments have examined its copper complex, GHK-Cu. In one study, researchers applied GHK-Cu to excised human skin in diffusion cells: copper associated with the tripeptide formulation entered and was retained within skin tissue, and some crossed dermatomed skin during the 48-hour experiment (Hostynek, Dreher & Maibach, Inflammation Research, 2011).
That is considerably stronger evidence than simply saying “GHK-Cu is under 500 Da, therefore it penetrates.” But there is an important limitation: the investigators measured copper rather than proving that every copper atom traveled through the skin while remaining attached to an intact GHK molecule. The authors specifically discussed the possibility of the complex dissociating and copper rebinding to molecules within the skin. So even here, “penetration” requires careful wording.
AHK-Cu: Small Enough, but Direct Delivery Data Are Limited
AHK-Cu — alanyl-histidyl-lysine complexed with copper — is another copper tripeptide. Depending on the precise chemical form being described, reported molecular weights differ: the copper complex without a chloride counterion has a formula weight of approximately 415.9 Da, while PubChem lists an AHK-Cu monohydrochloride form at 451.39 g/mol. Both are below the traditional 500-Da threshold, which makes AHK-Cu physically interesting for topical formulation.
It does not, however, prove scalp penetration. We could not identify a published human scalp penetration study demonstrating how much intact AHK-Cu from a finished cosmetic formulation reaches specific depths of the follicle.
There is biological research on AHK-Cu. In a 2007 study, AHK-Cu was applied directly to isolated human hair follicles and cultured human dermal papilla cells. At concentrations of 10-12 to 10-9 M, researchers reported increased follicle elongation ex vivo and increased dermal papilla cell proliferation in vitro (Pyo et al., Archives of Pharmacal Research, 2007).
That is intriguing early-stage evidence. But isolated follicles sitting in culture medium do not have the same delivery barrier as intact human scalp. The study tells us what AHK-Cu can do under those experimental conditions; it does not establish what concentration reaches dermal papilla cells after someone applies an AHK-Cu cosmetic to their scalp.
The Hair Follicle May Be Another Delivery Route
Skin penetration is also more complicated than traveling straight through the stratum corneum. Hair follicles create openings extending downward from the skin surface, and research increasingly recognizes follicles as potential reservoirs and pathways for topically applied substances — with particularly strong follicular accumulation shown for appropriately designed particulate delivery systems (Patzelt et al., Journal of Controlled Release, 2011).
That does not prove that every peptide automatically travels down a follicle. Formulation, molecular properties, vehicle, concentration, contact time and the physical behavior of the product all matter — and evidence from nanoparticles or specialized delivery systems cannot simply be transferred to an ordinary hair mask.
What Does “Delivery” Actually Mean?
This is where cosmetic marketing can become confusing. “Delivered to the skin” might mean the ingredient was deposited in the stratum corneum. “Skin penetration” might mean some material entered the epidermis. “Follicular delivery” might mean material accumulated somewhere inside the follicular canal. And “transdermal delivery” usually means material crossed the skin barrier entirely. Those are not interchangeable claims.
For peptide cosmetics, the scientifically responsible question is therefore not simply “Is this peptide under 500 Daltons?” It is: how much intact peptide reaches the intended location, from this particular formulation, under realistic conditions?
For AHK-Cu, its relatively small molecular size makes topical delivery scientifically plausible enough to investigate, and laboratory research provides an interesting biological rationale. But direct human evidence connecting application of a finished AHK-Cu scalp cosmetic with delivery to follicular target cells remains limited. The science is promising at the laboratory level, not clinically proven in people.
For readers who want to explore a cosmetic containing this ingredient, the RootMira AHK-Cu Copper Peptide Hair Mask combines AHK-Cu with a conditioning hair-mask format designed for use on the hair and scalp. It is a cosmetic way to incorporate a copper peptide into a hair-care routine — without pretending that early laboratory findings are the same thing as human clinical proof.
RootMira products are cosmetics, not medicines. This article shares general ingredient information, not medical advice.